Inventor · disambiguated record
Sanjeev Kumar Mendiratta
Also filed as: MENDIRATTA SANJEEV K · MENDIRATTA SANJEEV KUMAR
9 granted patents·10 pending applications·20 citations·filing 2005–2022
82Inventor score
Files withCADILA HEALTHCARE LTD11SINGH ARUN K2BANDYOPADHYAY SANJAY1CADILA HELTHCARE LTD1CADILLA HEALTHCARE LTD1
Top patents by PatentIndex Score
19 records- 0186US9708365B2Purification process for monoclonal antibodiesCADILA HEALTHCARE LTD·Filed 2014·Granted Jul 18, 2017·12 cites·34 claims
- 0275US10093728B2Pharmaceutical formulations of TNF-alpha antibodiesCADILA HEALTHCARE LTD·Filed 2013·Granted Oct 9, 2018·4 cites·11 claims
- 0375US9163257B2Expression vector and methods of producing high levels of proteinsSINGH ARUN K·Filed 2006·Granted Oct 20, 2015·2 cites·19 claims
- 0466US2023047111A1Pharmaceutical formulations of tnf-alpha antibodiesCADILA HEALTHCARE LTD·Filed 2022·Application pending·0 cites
- 0565US7923220B2Process for preparing high levels of interferon betaCADILA HEALTHCARE LTD·Filed 2005·Granted Apr 12, 2011·2 cites·13 claims
- 0654US9260721B2Expression vector and methods of producing high levels of proteinsSINGH ARUN K·Filed 2012·Granted Feb 16, 2016·0 cites·14 claims
- 0754US8021862B2Process for preparing human G-CSFCADILLA HEALTHCARE LTD·Filed 2007·Granted Sep 20, 2011·0 cites·12 claims
- 0851US8367054B2Formulations of PEG-interferon alpha conjugatesCADILA HEALTHCARE LTD·Filed 2007·Granted Feb 5, 2013·0 cites·19 claims
- 0950US2019071496A1Pharmaceutical formulations of tnf-alpha antibodiesCADILA HEALTHCARE LTD·Filed 2018·Application pending·0 cites
- 1045US2023183353A1Fc variant and preparation thereofZYDUS LIFESCIENCES LTD·Filed 2021·Application pending·0 cites
- 1144US8492120B2Process for preparing human G-CSFMENDIRATTA SANJEEV KUMAR·Filed 2010·Granted Jul 23, 2013·0 cites·3 claims
- 1244US2016215319A1Improved process for production of monoclonal antibodiesCADILA HELTHCARE LTD·Filed 2014·Application pending·0 cites
- 1344US2016200792A1Purification Process for PTHCADILA HEALTHCARE LTD·Filed 2014·Application pending·0 cites
- 1442US2018311375A1Process of preparing antibody-drug conjugateCADILA HEALTHCARE LTD·Filed 2018·Application pending·0 cites
- 1542US2021330801A1Novel protein drug conjugate formulationCADILA HEALTHCARE LTD·Filed 2018·Application pending·0 cites
- 1638US2014147896A1Enzyme for the production of optically pure 3-quinuclidinolCADILA HEALTHCARE LTD·Filed 2011·Application pending·0 cites
- 1735US2013244280A1Expression vector for high level expression of recombinant proteinsPARIKH AASHINI·Filed 2011·Application pending·0 cites
- 1831US2017029482A1Novel purification process of gonadotropinCADILA HEALTHCARE LTD·Filed 2015·Application pending·0 cites
- 1925US9175281B2Process for the purification of tissue plasminogen activatorBANDYOPADHYAY SANJAY·Filed 2011·Granted Nov 3, 2015·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Sanjeev Kumar Mendiratta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →